Morgan Stanley's Optimistic Outlook on Mahanagar Gas

Morgan Stanley has begun its coverage of Mahanagar Gas with an 'overweight' rating, setting a target price of Rs 1,606, indicating a 26% potential upside. The firm highlights the growing demand for natural gas in Mumbai, facilitated by MGL, as a pivotal factor for the company's growth. Despite anticipating lower margins, the analysts expect higher volume growth, which could significantly re-rate the stock.

Macquarie's Cautious Stance on United Spirits

On the other hand, Macquarie advises an 'underperform' rating for United Spirits, with a target price of Rs 1,175, suggesting a 17% downside. The recent resignation of the company's CEO has raised concerns, with analysts emphasizing the importance of a smooth leadership transition for the company's future performance.

Elara Securities' Sell Recommendation for HCL Technologies

Elara Securities India has issued a 'sell' recommendation for HCL Technologies, targeting a price of Rs 1,570, which is 14% below the current level. Despite acknowledging the company's growth potential in its three core businesses, analysts believe the stock's current valuation leaves little room for significant upside.

Emkay Global's Buy Call on Dixon Technologies

Meanwhile, Emkay Global Financial Services has initiated coverage on Dixon Technologies with a 'buy' rating, setting an ambitious target price of Rs 20,000, reflecting a 23% upside. The firm cites multiple long-term growth drivers, including opportunities in smartphone and IT hardware manufacturing, and expects sharp margin improvements.

Anand Rathi's Positive Take on Aster DM Healthcare

Lastly, Anand Rathi Share & Stock Brokers has started coverage on Aster DM Healthcare with a 'buy' recommendation and a target price of Rs 630, indicating a 26% potential increase. Analysts are optimistic about the company's growth prospects, citing synergies from the merger with Quality Care, backing from prominent investors like Blackstone, and strong profitability indicators.